Cancer

Disease State Hub

Slideshows

Research Summaries

FDA Alert

FDA Grants Accelerated Approval for First CAR-T Cell Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

04/22/2024

Anthony Calabro, MA

The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.

04/22/2024

Research Summary

Research Summary

Screening, Improved Metastatic Treatments Responsible For Substantial Decline in Breast Cancer Mortality Rate

02/07/2024

Anthony Calabro, MA

Using data from observational and clinical trials, researchers examined the association between advancements in metastatic breast cancer treatment and the observed improvement in breast cancer mortality...

02/07/2024

Research Summary

USPSTF Draft Recommendation Calls for Screening for Breast Cancer Every Other Year, Starting at Age 40

05/09/2023

Anthony Calabro, MA

The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.

05/09/2023

Research summary

Brain Metastases in Patients With Metastatic Uveal Melanoma

04/29/2023

Jessica Ganga

A group of researchers aimed to determine the incidence rate of brain metastases in patients with metastatic uveal melanoma using data from comprehensive cancer centers.

04/29/2023

Conference Coverage

Low-Dose Gemcitabine Beneficial Treatment for Platinum-Resistant Ovarian Cancer

04/21/2023

Jessica Ganga

Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...

04/21/2023

April 2026

Current Issue

April 2026